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Problem Identification

The Evidence: MCN or NFT?

Traumatic brain injury (TBI) often has serious consequences over the long term (Reddy et al.,
2014) and is typically a result of acceleration-deceleration accidents, athletic trauma or blasts
(Kerson, 2014). Consequences of TBI often profoundly impact daily quality of life, especially in
first responders and veterans and are manifested as sustained physical, cognitive, emotional
and behavioral problems (Lafee, 2017). While therapies have been in existence for decades,
evidence is inconsistent and lacking regarding alternative modalities, such as neurofeedback
training (NFT). IASIS microcurrent neurofeedback (MCN) is a more recently developed
contemporary technology as compared to traditional NFT that has been used for the past several
decades. A wide body of anecdotal evidence supports the effectiveness of MCN for treating TBI
(Shallenberger, 2018). Advantages of MCN over traditional neurofeedback include (a) it is the
first technology demonstrating effectiveness using image-based evidence, (b) sessions are
shorter in duration, and (c) sustainability of positive outcomes occur sooner (IASIS, 2018).
However, NFT has been around for decades and has also demonstrated effectiveness. This led
to a spirit of inquiry by a group undergraduate nursing research students to compare TBI
outcomes using the newer MCN therapy with the more traditional NFT in persons with mild TBI
(mTBI).

The Clinical Question: PICOT
The literature search was guided by the following PICOT question: In patients with mTBI (P),
how does MCN therapy (I) compared to NFT therapy (C) affect the reduction of TBI cognitive
symptoms (O) within the therapy’s duration (T)? For the intervention style question, the
hierarchy evidence is rated from Level I to Level VII. The literature review culminated in
evidence located that reflected Levels 1, 2, 3 and 7.

PURPOSE
Critical Appraisal of the Evidence
METHODS

Level 1: NFT A systematic study (May et al., 2013)
reviewed 23 studies that explored effects of NFT on
TBI. All reviewed reports showed improvements in
mild-moderate TBI with both subjective and objective
data.
Level 2: NFT Rostani et al. (2017) studied effects of
NFT with mild TBI in 17 patients, 8 in intervention and 5
in control groups. No significant effects on memory and
concentration.
Level 3: NFT Munivenkatappa et al. (2014) tested
EEG—NFB on 2 subjects, aged 12 and 20 to see
effects on white and grey brain matter; 20 sessions,
3/week; . Both were significantly enlarged post NFT,
indicating improved cognitive functioning.
Level 3: NFT Reddy et al. (2014) studied NFT on QOL
on 60 subjects; QOL significantly improved after 20
sessions 95-6/week).
Level 3: MCN Huang et al. (2017): first and only MCN
due to newness; low intensity pulse transcranial
electrical stimulation (LIP-tES) treatment that monitors
brain waves, utilizing magnetoencephalography (MEG)
exams for neuroimaging; Six with 1 drop out; all except
drop out showed significant improvement in TBI-related
post concussive symptoms.
Level 7: NFT Reid-Chung et al. (2015) demonstrated
through three clinical case studies that a combination of
biofeedback and NFT “can” improve heart rate
variability with those who have TBI. Kerson, 2014)
discussed an interview with the President of
International Society for Neurofeedback and Research
who stated too few academics are interested in
research and research that has been done lacks rigor
due to lack of collaboration with those knowledgeable
about and skilled in NFT. Gray (2017) discusses a
newer generation of NFT, quantitative EEG (qEEG) that
helps to improve clinical sensitivity; current evidence
flawed and lacks rigor.

The one MCN study and three research articles located within the past six years
lacked significant rigor and consequently led the reviewers to question results.
Small sample sizes, lack of sham for control, lack of control group, lack of
randomization, lack of transparency regarding other methodological issues
(protocols, length of treatment, inclusion criteria), sample heterogeneity, and
variability in length of time post TBI all contributed to weak internal and external
validity. According to Shallenberger (2018), MCN does more than treat the
symptoms….MCN repairs the underlying neurological mechanisms contributing
to the devastating symptoms of PTSD and TBI. There is a critical lack of science
to validate the scientific effectiveness to be able to promote MCN as something
to once again give hope and meaning to the lives of thousands of veterans
suffering from TBI and PTSD. With the one study at UC San Diego in progress
with the veteran population, and two additional ones planned to be implemented
in late May 2019 in East Texas, efforts will be maximized to ensure these studies
reflect optimal internal and external validity. NFT research has been in progress
for decades, but the research on TBI in the past six years is extremely limited
and significantly lacks rigor.
Due to the lack of evidence and lack of rigor in existing research, no decision
can be made as to whether or not IASIS MCN or NFT is more effective. In order
to establish evidence sound enough for practice, the following must be
incorporated into future studies: a) larger and more homogenous samples, b)
Double blind studies with a sham treatment therapy using subjects with a variety
of age groups and genders, c) outcomes that combine the use of imaging e.g.
the MEG (Huang, 2017) along with appropriate psycho-social and cognitive
functioning tools, d) longitudinal studies to explore sustainability of interventions
post treatment, e) transparency of protocols and equipment used and
consistency of their use within studies.

Evidence Integrated with Clinical Expertise and
Patient Preferences to Inform a Practice Change
Decision
Due to very limited evidence for both MCN and traditional NFB, and lack of study
rigor in those that are published, no practice decision can be made at this time. This
leads to the conclusion that more Level 2 research is needed and must be conducted
to meet criteria for internal and external validity. A VA-funded, double-blinded, 4 year
RCT is entering its 2nd year at University of CA, San Diego to determine the effects of
MCN on TBI and PTSD in combat veterans.

Implications for East Texas
This evidence-based practice project is extremely relevant to East Texas due to the
large numbers of combat veterans in this area. Percentages of veterans battling PTSD
are as follows: Vietnam War 31%, Gulf War 12-24%, Iraq War 11-30% and Afghan War
14%. The suicide rate for veterans is 1 in 20 and only 14% of those who need help are
actually getting it, with 40% determined to be unresponsive to treatments considered
evidenced based (Project Healing Heroes, DU). We know there are major gaps in
accessing quality care through the VA system and this is for many veterans their only
viable source of healthcare. TBI and post concussive symptoms are extremely difficult
to treat in military personnel, and these consequences are all too frequently observed
in veterans who are homeless, jobless, have few if any, social contacts, and essentially
have lost their purpose or meaning in life. With the advent of the relatively new MCN,
certified practitioners report overwhelmingly positive anecdotal evidence regarding the
effectiveness of MCN in military personnel suffering from TBI. Anecdotal evidence also
contributes to MCN potentially being more effective to the “treatment resistant” veteran
suffering from TBI and PTSD. The reviewers of this EBP project firmly believe that we
have an ethical and professional obligation to meet the needs of those who serve to
protect our country and who seemingly have the most problems accessing quality care.

NOTE: While this review did not focus on veterans with TBI, it was spurred by the passion of the
primary author to address the major problem of PTSD experienced by veterans in our community.
Three IASIS providers in Tyler have treated veterans with seemingly hopeless futures with incredible
results. While the published evidence is favorable toward NFT, there are clear advantages of IASIS
MCN over traditional NFT as indicated in the tables below. The special population of veterans and
Active Duty military personnel are underserved and when considering the sacrifices on their part
made on behalf of our country and communities, it is incumbent on us to facilitate credible and
rigorous scientific evidence in order to have available more effective strategies to positively impact
their daily quality of life. It is the least we can do.

TRADITIONAL NFT

IASIS MCN

IASIS MCN
Subject can be passive and engaged in
activity, e.g. reading, or just relax; no
interaction required; Only 1 published pilot
study with few rigor flaws; Evidence imagebased per MEG that showed significant
improved brain electrical activity; Results are
seen sooner; Enduring sustainability attained
sooner; Anecdotal evidence that veterans with
extreme moderate, early-severe PTSD are
improved.

NFT
Requires interaction and concentration by
person receiving it; Longer history of evidence of
effectiveness, but published studies lack rigor on
many levels; One study showed white and grey
matter growth; May take several sessions longer
to see results; Difficult to determine due to lack
of anecdotal or evidence; Not recommended for
anyone with severe TBI due to anticipated
ineffectiveness (Homecoming for Veterans, DU).

